| Primary |
| Chronic Obstructive Pulmonary Disease |
100.0% |
|
| Stress Cardiomyopathy |
100.0% |
|
| Secondary |
| Product Used For Unknown Indication |
31.1% |
| Chronic Obstructive Pulmonary Disease |
18.9% |
| Drug Use For Unknown Indication |
16.4% |
| Asthma |
13.1% |
| Breast Cancer |
4.1% |
| Parkinson's Disease |
3.3% |
| Viral Infection |
2.5% |
| Bronchitis |
1.6% |
| Dyslipidaemia |
1.6% |
| Hypertension |
1.6% |
| Chronic Respiratory Failure |
0.8% |
| Epilepsy |
0.8% |
| Hepatitis C |
0.8% |
| Hypercholesterolaemia |
0.8% |
| Oesophagitis |
0.8% |
| Osteoporosis |
0.8% |
| Thyroid Disorder |
0.8% |
|
| Syndactyly |
9.1% |
| Wrong Drug Administered |
9.1% |
| Asthma |
6.1% |
| Lung Disorder |
6.1% |
| Pulmonary Embolism |
6.1% |
| Septic Shock |
6.1% |
| Somnolence |
6.1% |
| Suicide Attempt |
6.1% |
| Syncope |
6.1% |
| Throat Irritation |
6.1% |
| Visual Impairment |
6.1% |
| Drug Exposure During Pregnancy |
3.0% |
| Eczema |
3.0% |
| Increased Bronchial Secretion |
3.0% |
| Malaise |
3.0% |
| Prostatic Adenoma |
3.0% |
| Pulmonary Infarction |
3.0% |
| Stress Cardiomyopathy |
3.0% |
| Toxic Skin Eruption |
3.0% |
| Weight Decreased |
3.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
32.7% |
| Drug Use For Unknown Indication |
22.5% |
| Hypertension |
6.0% |
| Bronchopneumopathy |
5.3% |
| Cardiac Failure |
4.7% |
| Asthma |
4.6% |
| Lung Infection |
3.1% |
| Rheumatoid Arthritis |
2.5% |
| Bronchitis |
2.4% |
| Bronchopulmonary Aspergillosis |
2.4% |
| Haemolytic Uraemic Syndrome |
2.4% |
| Chronic Obstructive Pulmonary Disease |
1.9% |
| Diabetes Mellitus |
1.4% |
| Pain |
1.4% |
| Aspergillosis |
1.3% |
| Depression |
1.2% |
| Atrial Fibrillation |
1.0% |
| Chronic Lymphocytic Leukaemia |
1.0% |
| Dyslipidaemia |
1.0% |
| Osteoporosis |
1.0% |
|
| Weight Increased |
9.8% |
| Pulmonary Embolism |
8.8% |
| Tendonitis |
8.8% |
| Thrombocytopenia |
7.8% |
| Hyponatraemia |
6.9% |
| Renal Failure |
6.9% |
| Renal Failure Acute |
6.9% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
4.9% |
| Cytolytic Hepatitis |
3.9% |
| Renal Failure Chronic |
3.9% |
| Somnolence |
3.9% |
| Vomiting |
3.9% |
| Bronchopulmonary Aspergillosis |
2.9% |
| Cardio-respiratory Arrest |
2.9% |
| Cholestasis |
2.9% |
| Dyspnoea |
2.9% |
| Malaise |
2.9% |
| Myalgia |
2.9% |
| Respiratory Failure |
2.9% |
| Swelling Face |
2.9% |
|
